Melaleuca CellWise and Other Vitamin Complexes May Help Fight Cancer | Benzinga

http://www.benzinga.com/pressreleases/12/09/p2948042/melaleuca-cellwise-and-other-vitamin-complexes-may-help-fight-cancer[10/14/15, 1:42:54 PM]

EUR/USD1.1446

+0.0065+0.57%

Dow16,984.00

-0.98-0.57%

S&P 5002,000.75

-2.94-0.15%

NASDAQ4,804.48

+7.87+0.16%

30yr T-Bond2.85

-0.04-1.52%

Melaleuca CellWise and Other Vitamin Complexes May Help Fight Cancer PRWeb FOLLOW

September 27, 2012 5:50pm Comments

Melaleuca's new vitamin and mineral complexes contain high amounts of antioxidants which studies have shown play a large part in the prevention of cellular damage and the occurrence of cancer.

San Diego, CA (PRWEB) September 27, 2012

Melaleuca, a wellness company that is named after a genus of Australian medicinal plants, has developed a patented anti-oxidant formula which may be able to help fight cancer. While the company is known for its concentrated eco-friendly cleaning products, it is also known for its development of many vitamin and mineral supplements.

One of the most promising formulas they have developed, in regards to cancer fighting abilities, is the broad spectrum antioxidant, CellWise. This complex contains both vitamin C (a powerful antioxidant) and Oglio, which is Melaleuca's patented formula that protects minerals. These combine to help reduce excess free radicals. Damage by free radicals, according to the National Cancer Institute, is what causes the occurrence of cancerous cells. Antioxidants help to protect against this damage, and even reverse it, by preventing the generation of free radicals in the body.

Aside from CellWise there are also other vitamin complexes in the Melaleuca line which could be useful in the prevention of cancer. The Vitality MultiVitamin and Supplement contains beta-carotene, vitamins C and E, and the mineral

selineum, all of which improve the functioning of the immune system and protect against free radicals.

Melaleuca's Vitality Calcium Complete, a calcium and vitamin D complex, is also purported to help keep your immune system healthy, as it provides a natural source of vitamin D. Usually, we get this vitamin in small amounts from the foods we eat; in things like eggs, milk and fish. However, one of the main sources of vitamin D is what we get when we are exposed to the UVB rays of the sun. While in small amounts, this has no harmful affects, too much sun exposure will also result in the development of free radicals. As such,

Benzinga Benzinga Pro Marketfy Financial Data & APIs Free Streaming News Contribute Login Sign Up

Trending Recent

Join TD Ameritrade. Get up to $600 and trade FREE for 60 days.

Get Benzinga's Newsletters

1 TEVA, AGN: Pfizer, Allergan Shares Pop After Buyout Rumor2 FIT: These Fitbit Numbers Make The Stock A Screaming Buy3 NFLX: Bob Peck: Netflix Worth $110 Sum-Of-Parts, But Be Cautious Of In...4 JPM, WFC: Keep an Eye on These 10 Stocks for October 14, 20155 GLD, CVX: Jim Cramer Gives His Opinion On SPDR Gold Trust,...6 DELL, VMW: PacCrest's Owens Sees 'Many Q...7 October 13 Earnings Update

Home News Markets Ratings Ideas Tech Small-Cap Personal Finance Premium ProductsMy Watchlist

News Markets Ratings Ideas Tech Small-Cap Personal Finance Premium Products

http://www.facebook.com/pages/Benzingacom/159483118580?v=app_7146470109http://twitter.com/benzingahttp://www.linkedin.com/company/benzingahttps://plus.google.com/108838891574408087738/postshttp://feeds.benzinga.com/benzingahttp://www.benzinga.com/http://www.benzinga.com/users/prwebhttp://trustedhomebusinessreviews.com/melaleuca/http://www.benzinga.com/http://pro.benzinga.com/http://marketfy.com/http://cloud.benzinga.com/http://www.benzinga.com/widgets/live-updateshttp://www.benzinga.com/contributehttp://www.benzinga.com/userhttp://www.benzinga.com/userjavascript:void(0)javascript:void(0)javascript:void(0)javascript:void(0)https://adclick.g.doubleclick.net/aclk?sa=L&ai=BPigAgpIeVsc8xYAxwJ2e4AyLmLb3BwAAABABIAA4AFjLgIWJigJgyYaAgNCj2BCCARdjYS1wdWItNTY0OTg5NDg4OTUzNzcxOLIBEHd3dy5iZW56aW5nYS5jb226AQlnZnBfaW1hZ2XIAQnaAXlodHRwOi8vd3d3LmJlbnppbmdhLmNvbS9wcmVzc3JlbGVhc2VzLzEyLzA5L3AyOTQ4MDQyL21lbGFsZXVjYS1jZWxsd2lzZS1hbmQtb3RoZXItdml0YW1pbi1jb21wbGV4ZXMtbWF5LWhlbHAtZmlnaHQtY2FuY2VywAIC4AIA6gIcLzUyMDYvaW52Yy5iZW56aW5nYS9lcXVpdGllc_gChNIekAPgA5gD4AOoAwHQBJBO4AQBkAYBoAYg2AcA&num=0&cid=5GhgHhB0CiSnTpiqGGVLi81z&sig=AOD64_1l0qsd5_zcUtMPZny-yOYljxiR5A&client=ca-pub-5649894889537718&adurl=https://ad.doubleclick.net/ddm/clk/292548482;119665068;vhttps://adclick.g.doubleclick.net/aclk?sa=L&ai=BPigAgpIeVsc8xYAxwJ2e4AyLmLb3BwAAABABIAA4AFjLgIWJigJgyYaAgNCj2BCCARdjYS1wdWItNTY0OTg5NDg4OTUzNzcxOLIBEHd3dy5iZW56aW5nYS5jb226AQlnZnBfaW1hZ2XIAQnaAXlodHRwOi8vd3d3LmJlbnppbmdhLmNvbS9wcmVzc3JlbGVhc2VzLzEyLzA5L3AyOTQ4MDQyL21lbGFsZXVjYS1jZWxsd2lzZS1hbmQtb3RoZXItdml0YW1pbi1jb21wbGV4ZXMtbWF5LWhlbHAtZmlnaHQtY2FuY2VywAIC4AIA6gIcLzUyMDYvaW52Yy5iZW56aW5nYS9lcXVpdGllc_gChNIekAPgA5gD4AOoAwHQBJBO4AQBkAYBoAYg2AcA&num=0&cid=5GhgHhB0CiSnTpiqGGVLi81z&sig=AOD64_1l0qsd5_zcUtMPZny-yOYljxiR5A&client=ca-pub-5649894889537718&adurl=https://ad.doubleclick.net/ddm/clk/292548482;119665068;vhttp://www.benzinga.com/general/biotech/15/10/5908955/pfizer-allergan-shares-pop-after-buyout-rumorhttp://www.benzinga.com/general/biotech/15/10/5908955/pfizer-allergan-shares-pop-after-buyout-rumorhttp://www.benzinga.com/general/biotech/15/10/5908955/pfizer-allergan-shares-pop-after-buyout-rumorhttp://www.benzinga.com/general/biotech/15/10/5908955/pfizer-allergan-shares-pop-after-buyout-rumorhttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5908223/these-fitbit-numbers-make-the-stock-a-screaming-buyhttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5908223/these-fitbit-numbers-make-the-stock-a-screaming-buyhttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5908223/these-fitbit-numbers-make-the-stock-a-screaming-buyhttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5908223/these-fitbit-numbers-make-the-stock-a-screaming-buyhttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5907912/bob-peck-netflix-worth-110-sum-of-parts-but-be-cautious-http://www.benzinga.com/analyst-ratings/analyst-color/15/10/5907912/bob-peck-netflix-worth-110-sum-of-parts-but-be-cautious-http://www.benzinga.com/analyst-ratings/analyst-color/15/10/5907912/bob-peck-netflix-worth-110-sum-of-parts-but-be-cautious-http://www.benzinga.com/analyst-ratings/analyst-color/15/10/5907912/bob-peck-netflix-worth-110-sum-of-parts-but-be-cautious-http://www.benzinga.com/news/earnings/15/10/5911056/keep-an-eye-on-these-10-stocks-for-october-14-2015http://www.benzinga.com/news/earnings/15/10/5911056/keep-an-eye-on-these-10-stocks-for-october-14-2015http://www.benzinga.com/news/earnings/15/10/5911056/keep-an-eye-on-these-10-stocks-for-october-14-2015http://www.benzinga.com/news/earnings/15/10/5911056/keep-an-eye-on-these-10-stocks-for-october-14-2015http://www.benzinga.com/media/cnbc/15/10/5906591/jim-cramer-gives-his-opinion-on-spdr-gold-trust-randgold-resources-chevron-http://www.benzinga.com/media/cnbc/15/10/5906591/jim-cramer-gives-his-opinion-on-spdr-gold-trust-randgold-resources-chevron-http://www.benzinga.com/media/cnbc/15/10/5906591/jim-cramer-gives-his-opinion-on-spdr-gold-trust-randgold-resources-chevron-http://www.benzinga.com/media/cnbc/15/10/5906591/jim-cramer-gives-his-opinion-on-spdr-gold-trust-randgold-resources-chevron-http://www.benzinga.com/analyst-ratings/analyst-color/15/10/5908346/paccrests-owens-sees-many-questions-for-vmware-nowhttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5908346/paccrests-owens-sees-many-questions-for-vmware-nowhttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5908346/paccrests-owens-sees-many-questions-for-vmware-nowhttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5908346/paccrests-owens-sees-many-questions-for-vmware-nowhttp://www.benzinga.com/trading-ideas/previews/15/10/5643986/october-13-earnings-updatehttp://www.benzinga.com/trading-ideas/previews/15/10/5643986/october-13-earnings-updatehttp://www.benzinga.com/http://www.benzinga.com/newshttp://www.benzinga.com/marketshttp://www.benzinga.com/analyst-ratingshttp://www.benzinga.com/trading-ideashttp://www.benzinga.com/techhttp://www.benzinga.com/news/small-caphttp://www.benzinga.com/personal-financehttp://marketfy.com/http://www.benzinga.com/userhttp://www.benzinga.com/newshttp://www.benzinga.com/marketshttp://www.benzinga.com/analyst-ratingshttp://www.benzinga.com/trading-ideashttp://www.benzinga.com/techhttp://www.benzinga.com/news/small-caphttp://www.benzinga.com/personal-financehttp://marketfy.com/http://www.benzinga.com/TINAHighlight

TINAHighlight

TINAHighlight

TINAHighlight

Melaleuca CellWise and Other Vitamin Complexes May Help Fight Cancer | Benzinga

http://www.benzinga.com/pressreleases/12/09/p2948042/melaleuca-cellwise-and-other-vitamin-complexes-may-help-fight-cancer[10/14/15, 1:42:54 PM]

the vitamin complex offers a safe and natural way to obtain this nutrient.

While Frank Vandersloot, the founder of Melaleuca, ensures that all products that are produced are 100% safe and of the highest quality, the claims about the vitamin complexes are not FDA tested. However, studies have shown that having a healthy lifestyle, which is supplemented with a quality diet and consumption of antioxidants in foods and supplement form, can help prevent the occurrence of cancer and many other preventable diseases. A full Melaleuca review gives more information on the company.

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebmelaleuca/cellwise/prweb9944953.htm

View Comments and Join the Discussion!

View upcoming Earnings, Ratings, Dividend and Economic Calendars.

01:29 PM Nike Issues Release Confirming $50B in Sales by End of FY2020

1:28 PM Nike Issues Release Confirming $50B in Sales by End of FY2020

1:27 PM Lockheed Martin Shares Seeing Selling Pressure, Currently At LOD Of $210.63

1:25 PM UPDATE: MKM Analyst on EA Upgrade: 'Higher Star Wars: Battlefront Expectations Driving FY16 Estimates Higher'

http://trustedhomebusinessreviews.com/melaleuca/http://trustedhomebusinessreviews.com/melaleuca/http://www.prweb.com/releases/prwebmelaleuca/cellwise/prweb9944953.htmhttp://limited.benzinga.com/bzcom/?utm_campaign=Benzinga&utm_medium=-&utm_source=Unbounce&utm_content=onedollarhttp://limited.benzinga.com/bzcom/?utm_campaign=Benzinga&utm_medium=-&utm_source=Unbounce&utm_content=onedollarhttp://www.benzinga.com/calendar/earningshttp://www.benzinga.com/calendar/earningshttp://www.benzinga.com/news/15/10/5913274/nike-issues-release-confirming-50b-in-sales-by-end-of-fy2020http://www.benzinga.com/news/15/10/5913274/nike-issues-release-confirming-50b-in-sales-by-end-of-fy2020http://www.benzinga.com/news/15/10/5913271/nike-issues-release-confirming-50b-in-sales-by-end-of-fy2020http://www.benzinga.com/news/15/10/5913271/nike-issues-release-confirming-50b-in-sales-by-end-of-fy2020http://www.benzinga.com/movers/15/10/5913268/lockheed-martin-shares-seeing-selling-pressure-currently-at-lod-of-210-63http://www.benzinga.com/movers/15/10/5913268/lockheed-martin-shares-seeing-selling-pressure-currently-at-lod-of-210-63http://www.benzinga.com/movers/15/10/5913268/lockheed-martin-shares-seeing-selling-pressure-currently-at-lod-of-210-63http://www.benzinga.com/analyst-ratings/analyst-color/15/10/5913266/update-mkm-analyst-on-ea-upgrade-higher-star-wars-battlehttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5913266/update-mkm-analyst-on-ea-upgrade-higher-star-wars-battlehttp://www.benzinga.com/analyst-ratings/analyst-color/15/10/5913266/update-mkm-analyst-on-ea-upgrade-higher-star-wars-battle

Melaleuca CellWise and Other Vitamin Complexes May Help Fight Cancer | Benzinga

http://www.benzinga.com/pressreleases/12/09/p2948042/melaleuca-cellwise-and-other-vitamin-complexes-may-help-fight-cancer[10/14/15, 1:42:54 PM]

1 (877) 440-9464 (ZING) © Copyright Benzinga

Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content.

Analyst Ratings

Be Your Own Boss

ETFs

Economics

Forex

Hot

News

Options

Press Releases

Start-ups

Tech

Popular Channels

Affiliate Program

Feeds

News Widget

Real Time Feed

Sitemap

Submit News Tips

Tools & Features

About Us

Licensing and APIs

Apps (iOS and Android)

Fintech Awards

Blog

In the News

Careers

Contact Us

Disclaimer

Privacy Policy

Syndication

Terms and Conditions

About Benzinga Benzinga Partners

http://www.benzinga.com/analyst-ratingshttp://www.benzinga.com/be-your-own-bosshttp://www.benzinga.com/etfshttp://www.benzinga.com/economicshttp://www.benzinga.com/markets/forexhttp://www.benzinga.com/hothttp://www.benzinga.com/newshttp://www.benzinga.com/markets/optionshttp://www.benzinga.com/pressreleaseshttp://www.benzinga.com/startupshttp://www.benzinga.com/techhttp://benzinga.postaffiliatepro.com/affiliateshttp://www.benzinga.com/feeds/listhttp://www.benzinga.com/partners/widgetshttp://www.benzinga.com/widgets/live-updateshttp://www.benzinga.com/sitemaphttp://www.benzinga.com/contacthttp://www.benzinga.com/abouthttp://cloud.benzinga.com/http://www.benzinga.com/appshttp://benzingafintechawards.com/http://www.benzinga.com/bloghttp://www.benzinga.com/inthenewshttp://jobs.benzinga.com/http://www.benzinga.com/contacthttp://www.benzinga.com/disclaimerhttp://www.benzinga.com/page/privacyhttp://www.benzinga.com/syndicationhttp://www.benzinga.com/terms-and-conditions

benzinga.comMelaleuca CellWise and Other Vitamin Complexes May Help Fight Cancer | Benzinga

1heS1oZWxwLWZpZ2h0LWNhbmNlcgA=: form0: button7: query: Tickers, Articles & Keywords

1heS1oZWxwLWZpZ2h0LWNhbmNlcgA=: button5:

1heS1oZWxwLWZpZ2h0LWNhbmNlcgA=: form1: email_id: Email Addressop: